Gioulnar I Harvie

Title: Gioulnar I Harvie: Innovator in Rare Cell Detection

Introduction

Gioulnar I Harvie is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biological sample analysis, particularly in the detection and isolation of rare cells. His innovative work has the potential to impact cancer research and diagnostics.

Latest Patents

Gioulnar holds a patent for "Methods and compositions for detecting rare cells from a biological sample." This patent outlines methods and compositions for isolating and detecting rare cells from biological samples that contain other cell types. The invention includes a microfabricated filter for filtering samples, which allows for the enrichment of rare cells. These enriched cells can be utilized in downstream processes such as identification, characterization, or growth in culture. Additionally, the patent describes a method for determining tumor aggressiveness by detecting telomerase activity and nucleic acid expression after the enrichment of rare cells. The invention also provides an efficient method to specifically remove red and white blood cells from a sample, leading to the enrichment of various target cells, including circulating tumor cells.

Career Highlights

Gioulnar I Harvie is associated with Aviva Biosciences Corporation, where he continues to advance his research and innovations. His work is crucial in the development of technologies that enhance the detection of rare cells, which can play a vital role in medical diagnostics and treatment strategies.

Collaborations

Gioulnar collaborates with notable colleagues, including Ping Lin and Andrea Ghetti. Their combined expertise contributes to the advancement of research in the field of rare cell detection.

Conclusion

Gioulnar I Harvie's contributions to the field of rare cell detection exemplify the importance of innovation in medical research. His patented methods and compositions have the potential to significantly enhance diagnostic capabilities and improve patient outcomes.